BMY

Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
$56.95
-2.39 (-4.03%)
Mkt Cap: 116.30B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield11.7%
Dividend YieldN/A
Market Cap116.30B
Volume14.06M
Recent News
Can BMY's CELMoD Program Advancements Strengthen Its Oncology Portfolio?
zacks.com · 2026-07-14
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
fool.com · 2026-07-14
Bristol Myers Squibb Moves Closer to New Multiple Myeloma Treatment
benzinga.com · 2026-07-13
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
businesswire.com · 2026-07-13
Start Investing At 60 And Retire On Dividends Forever
seekingalpha.com · 2026-07-10
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now
fool.com · 2026-07-07

Unlock the Full Deep Scan

9 AI agents analyze BMY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →